Logo KMS TEAM
Precise execution

MC Services is...

Client News

 

 

… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.

 

read more

 

MC Services hosted Press Lounge at the BIO-Europe 2016 in Cologne

 

This fall, Cologne hosted Europe’s largest partnering conference for the global biotechnology industry - BIO-Europe®. The event took place November 7-9 and had over 3,600 attendees from over 60 countries. MC Services was supporting BIO-Europe® as media partner and hosted the new conference Press Lounge: Centrally located in the exhibit hall – in the midst of activities – journalists were able to retreat to a quiet, fully-equipped work station or use the lounge area to conduct interviews or network with industry representatives.
 

Twitter: #BIOEurope 2016 #PressLounge

 

MC Services, EBD Group, BIO.NRW and LaBiotech.eu joined forces for BIO-Europe 2016 live blog

 

MC Services led a joint initiative with EBD Group, BIO.NRW LaBiotech.eu at BIO-Europe to introduce science journalist students from the “Kölner Journalistenschule” and the TU Dortmund to the biosciences industry. The students were invited to BIO-Europe to conduct interviews with participants and report their impressions of the event, as well as highlights from panels, company presentations and discussions. This content is available in a blog, designed for experts and generalists alike, with the aim of connecting the conference with international audiences and relevant local communities.

 

Please also follow us on Twitter (@MCServicesAG; #BIOEurope 2016)

 

The blog is available here

 

MC Services introduces “BIT” - the BIO-Europe® Investor Talks


During the course of the BIO-Europe 2016, MC Services conducted video interviews with some of the most prominent European investors/VCs in the life sciences space to capture their thoughts on current and future trends in the sector, how the investors are addressing these trends and what exit paths they are realistically seeing in Europe.

 

The interviews are available here

Cinfa Biotech publishes clinical data abstract at the 58th American Society of Hematology (ASH) Annual Meeting 2016

www.cinfabiotech.com

MagForce AG supports NOA Winter School 2016 from December 01-02 in Münster, Germany

www.magforce.de

VAXIMM Presents Preclinical Data on Three Novel Oral T-Cell Cancer Immunotherapies at EORTC-NCI-AACR Symposium

www.vaximm.com

co.don AG: early submission of document packages for EU marketing authorisation

www.codon.de

AiCuris Announces Start of LipP 1: First Subject Enrolled in the Clinical Phase 2 Trial with Topical Pritelivir for the Treatment of recurrent Labial Herpes

www.aicuris.com

SYGNIS AG announces publication in “Nature Communications” of the TruePrime™ novel method for whole genome amplification

www.sygnis.com

Ergomed strengthens PrimeVigilance with acquisition of European pharmacovigilance and regulatory services business, PharmInvent

www.ergomedplc.com

New Success with the Development of a Depolymerization Process at 100% of Plastic Bottles

www.carbios.fr

MorphoSys Announces That Its Licensee Janssen Has Submitted a Marketing Authorisation Application For Guselkumab in Europe

www.morphosys.de

SYGNIS AG reinforces its proteomics portfolio with two patents granted in Europe and China

www.sygnis.com

ABIVAX to Host Key Opinion Leader Luncheon for Investors Focused on Novel Approaches to HIV Therapy

www.abivax.com

RedHill Biopharma Announces YELIVA(TM) (ABC294640) Poster Presentation at the 2016 EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium

www.redhillbio.com